Insights on Intensive Vs Nonintensive Prerandomization Systolic Blood Pressure Reduction-Reply

Adnan I Qureshi^{1

2}, Wei Huang^{1

2}, Iryna Lobanova^{1

2}

Affiliations

Comment

Adnan I Qureshi et al. JAMA Neurol. 2021.

. 2021 May 1;78(5):620.

doi: 10.1001/jamaneurol.2021.0261.

Adnan I Qureshi^{1

2}, Wei Huang^{1

2}, Iryna Lobanova^{1

2}

No abstract available

Comment on

Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
Qureshi AI, Huang W, Lobanova I, Barsan WG, Hanley DF, Hsu CY, Lin CL, Silbergleit R, Steiner T, Suarez JI, Toyoda K, Yamamoto H; for ATACH-II trial investigators. Qureshi AI, et al. JAMA Neurol. 2020 Nov 1;77(11):1355-1365. doi: 10.1001/jamaneurol.2020.3075. JAMA Neurol. 2020. PMID: 32897310 Free PMC article. Review.
Insights on Intensive vs Nonintensive Prerandomization Systolic Blood Pressure Reduction.
Mahabala C, Varma P, Shenoy A. Mahabala C, et al. JAMA Neurol. 2021 May 1;78(5):619-620. doi: 10.1001/jamaneurol.2021.0258. JAMA Neurol. 2021. PMID: 33720277 No abstract available.